Histone Deacetylase Inhibitors: all 1,242 studies that test it

Page 13 of 13. Open to participants first (144), then studies with results posted, then the rest; newest registration first within each.

• Romidepsin in Treating Patients With Locally Advanced or Metastatic Neuroendocrine TumorsTerminatedNCT00084461Phase 2
• Efficacy and Safety of Seroquel Plus Mood Stabilizer in the Maintenance of Bipolar I DisorderCompletedNCT00081380Phase 3
• FR901228 Alone or Combined With Rituximab and Fludarabine in Treating Patients With Relapsed or Refractory Low-Grade B-Cell Non-Hodgkin's LymphomaTerminatedNCT00079443Phase 2
• Decitabine and Valproic Acid in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaCompletedNCT00079378Phase 1
• FR901228 in Treating Patients With Previously Treated Unresectable Locally Advanced or Metastatic Colorectal CancerCompletedNCT00077337Phase 2
• FR901228 in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaCompletedNCT00077194Phase 2
• Valproic Acid in Treating Patients With Kaposi's SarcomaCompletedNCT00075777Not applicable
• Phase I/II Study of Decitabine and Valproic Acid in Relapsed/Refractory Leukemia or Myelodysplastic SyndromesCompletedNCT00075010Phase 1/2
• A Study of the Safety and Efficacy of Depakote Sprinkle Capsules in the Treatment of Partial Seizures in ChildrenTerminatedNCT00067431Phase 3
• An Outpatient Study of the Effectiveness and Safety of Depakote ER in the Treatment of Mania/Bipolar Disorder in Children and AdolescentsCompletedNCT00067262Phase 3
• FR901228 in Treating Patients With Relapsed or Refractory Multiple MyelomaCompletedNCT00066638Phase 2
• Valproate Response in Aggressive Autistic AdolescentsStatus unknownNCT00065884Phase 3
• Romidepsin in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaCompletedNCT00062075Phase 2
• An Inpatient Study of the Effectiveness and Safety of Depakote ER in the Treatment of Mania/Bipolar DisorderCompletedNCT00060905Phase 3
• FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or LeukemiaCompletedNCT00053963Phase 1
• Depsipeptide to Treat Thyroid and Other Advanced CancersCompletedNCT00048334Phase 1
• Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced CancerCompletedNCT00045006Phase 1
• Pyroxamide in Treating Patients With Advanced CancerCompletedNCT00042900Phase 1
• FR901228 in Treating Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Non-Hodgkin's LymphomaCompletedNCT00042822Phase 2
• FR901228 in Treating Patients With Hematologic CancerCompletedNCT00024180Phase 1
• MS-275 in Treating Patients With Advanced Solid Tumors or LymphomaCompletedNCT00020579Phase 1
• FR901228 in Treating Patients With Refractory or Progressive Small Cell Lung Cancer or Non-small Cell Lung CancerCompletedNCT00020202Phase 2
• Depsipeptide in Treating Patients With Solid TumorsCompletedNCT00019318Phase 1
• Phenylbutyrate/Genistein Duotherapy in Delta F508-Homozygous(for Cystic Fibrosis)CompletedNCT00016744Phase 1/2
• MS-275 in Treating Patients With Hematologic CancerCompletedNCT00015925Phase 1
• Phenylbutyrate to Treat Children With Progressive or Recurrent Brain TumorsCompletedNCT00006450Phase 2
• Ganciclovir Plus Arginine Butyrate in Treating Patients With Cancer or Lymphoproliferative Disorders Associated With the Epstein Barr VirusCompletedNCT00006340Phase 1
• Phenylbutyrate, Dexamethasone, and Sargramostim in Treating Patients With Refractory or Relapsed Acute Myeloid LeukemiaCompletedNCT00006240Phase 2
• Phenylbutyrate and Tretinoin in Treating Patients With Hematologic CancerCompletedNCT00006239Phase 1
• Phase II Study of Arginine Butyrate With or Without Epoetin Alfa in Patients With Thalassemia IntermediaCompletedNCT00006136Phase 2
• Phenylbutyrate Plus Azacitidine in Treating Patients With Acute Myeloid Leukemia, Myelodysplasia, Non-Hodgkin's Lymphoma, Multiple Myeloma, Non-small Cell Lung Cancer, or Prostate CancerCompletedNCT00006019Phase 2
• Azacitidine Plus Phenylbutyrate in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous TreatmentCompletedNCT00005639Phase 1
• Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous TherapyCompletedNCT00005634Phase 1
• CI-994 in Treating Patients With Advanced MyelomaCompletedNCT00005624Phase 2
• Azacitidine Plus Phenylbutyrate in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic SyndromeCompletedNCT00004871Phase 1
• Phase III Double Blind Trial of Valproate Sodium for Prophylaxis of Post Traumatic SeizuresCompletedNCT00004817Phase 3
• Phase II Study of Sodium Phenylbutyrate, Sodium Benzoate, Sodium Phenylacetate, and Dietary Intervention for Urea Cycle DisordersCompletedNCT00004767Phase 2
• Phenylbutyrate in Treating Patients With Refractory Solid Tumors or LymphomaCompletedNCT00002909Phase 1
• Phase I-II Study of Fluorouracil in Combination With Phenylbutyrate in Advanced Colorectal CancerTerminatedNCT00002796Phase 1/2
• Phase I and Pharmacokinetic Trial of Phenylbutyrate Given as a Continuous Infusion in Pediatric Patients With Refractory MalignancyCompletedNCT00001565Phase 1
• The Effects of Valproic Acid on Zidovudine Glucuronidation and Pharmacokinetics in HIV-Infected Patients.CompletedNCT00000629Phase 1
• Drug Treatment for Alcoholics With Bipolar DisorderCompletedNCT00000439Phase 2

← Histone Deacetylase Inhibitors overview